DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2006

CCM DUOPHARMA BIOTECH BERHAD

Quarterly report for the financial period ended

30/06/2006
Quarter2
Financial Year End31/12/2006
The figureshave not been audited

Attachments

CCMDBIO-Q2 2006.xls
107 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2006 
30/06/2005 
30/06/2006 
30/06/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
27,493
26,487
54,907
48,692
2Profit/(loss) before tax
10,456
9,355
20,917
16,823
3Profit/(loss) for the period
7,747
5,665
15,371
11,570
4Profit/(loss) attributable to ordinary equity holders of the parent
7,747
5,665
15,371
11,570
5Basic earnings/(loss) per share (sen)
5.56
4.31
11.03
8.78
6Proposed/Declared dividend per share (sen)
7.00
0.00
7.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)

1.0000
1.0100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced23 Aug 2006  
CategoryFinancial Results
Reference NoCS-060807-38665